MINIMALLY INVASIVE DEVICE AND BIOABSORBABLE HEMOSTATIC POWDER FOR MANAGING NONCOMPRESSIBLE TORSO HEMORRHAGE

$2,000,000FY2021Defense Health AgencyDOD

Versiti Blood Health, Inc., Milwaukee WI

Investigators